Filter
268
Filtered Results: 268
Text search:
India
Hypertension
Control
Initiative
Featured
Recommendations
28
New Publications
90
Language
Document type
No document type
147
Studies & Reports
60
Guidelines
30
Manuals
15
Training Material
7
Strategic & Response Plan
6
Resource Platforms
2
Situation Updates
1
Countries / Regions
India
45
Latin America and the Carribbean
14
Global
10
South–East Asia Region
8
Ethiopia
7
Malawi
6
Venezuela
6
Kenya
5
Paraguay
5
Chile
4
Nigeria
4
Africa
4
Bangladesh
4
Myanmar / Burma
4
Nepal
3
Philippines
3
South Africa
3
Uganda
3
Brazil
3
Indonesia
3
Ukraine
2
Sierra Leone
2
Asia
2
North America
2
Bolivia
2
Argentina
2
Zambia
2
Pakistan
2
Colombia
1
Mexico
1
El Salvador
1
Ghana
1
Peru
1
Mozambique
1
Haiti
1
Tanzania
1
Congo, Democratic Republic of
1
Western and Central Europe
1
Moldova
1
Russia
1
Namibia
1
Authors & Publishers
Publication Years
Category
Countries
114
Clinical Guidelines
44
Public Health
26
Women & Child Health
14
Key Resources
8
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
NCDs
35
Mental Health
21
COVID-19
14
TB
11
Planetary Health
10
Global Health Education
10
HIV
9
Caregiver
9
Refugee
4
Disability
3
Pharmacy
3
Rapid Response
2
Natural Hazards
2
AMR
2
Ebola
1
Health Financing Toolbox
1
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and much-needed services for mental health. Combined with...
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv...
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
The chapter Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time, is part of the publication series titled “Decade of Healthy Aging: situation and challenges”. This document aims to provide an outline of the current situation in Latin America and the C...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that have transformed the global health landscape.
A all for global Action. The Oral Health Atlas. Second edition
UNAIDS Joint United Nations Programme on HIV/AIDS
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, les anomalies congénitales, la diarrhée, les tra...
